Clinical Trial Update: A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

View source ↗

Summary

A prospective study evaluating Stapokibart Injection for seasonal allergic rhinitis, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Stapokibart Injection (Stapokibart)

Snippet

Sponsor: Chengdu Kangnuoxing Biopharma,Inc. | Conditions: SAR | Status: NOT_YET_RECRUITING